Hedge Fund - OrbiMed Advisors
- Profile
- 13F Holdings
- Latest 13D & 13G Filings
- News, Interviews, and Investor Letters
News, Interviews, and Investor Letters
- 1 - 10
- Next >>
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
March 16th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
March 6th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
February 22nd, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Nabriva Therapeutics PLC – ADR (NBRV)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
January 26th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
January 26th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d‑1(e), 240....... (read more)
January 26th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
January 26th, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Xtant Medical Holdings Inc. (XTNT)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
January 23rd, 2018 - Hedge Funds - Comments
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d...... (read more)
January 8th, 2018 - Hedge Funds - Comments
- 1 - 10
- Next >>
Hedge Fund Resource Center